Alvotech Stock Analysis

ALVO Stock  USD 9.19  0.26  2.91%   
Alvotech is overvalued with Real Value of 7.91 and Target Price of 18.0. The main objective of Alvotech stock analysis is to determine its intrinsic value, which is an estimate of what Alvotech is worth, separate from its market price. There are two main types of Alvotech's stock analysis: fundamental analysis and technical analysis.
The Alvotech stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Alvotech is usually not traded on National Mourning Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day, Thanksgiving Day, Christmas Day, New Year 's Day. Alvotech Stock trading window is adjusted to America/New York timezone.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Alvotech. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.
To learn how to invest in Alvotech Stock, please use our How to Invest in Alvotech guide.

Alvotech Stock Analysis Notes

About 63.0% of the company shares are held by company insiders. The company had not issued any dividends in recent years. Alvotech, through its subsidiaries, develops and manufactures biosimilar medicines for patients worldwide. The company was founded in 2013 and is headquartered in Reykjavik, Iceland. Alvotech is traded on NASDAQ Exchange in the United States. For more info on Alvotech please contact the company at 354 422 4500 or go to https://www.alvotech.com.

Alvotech Quarterly Total Revenue

132.76 Million

Alvotech Investment Alerts

Alvotech had very high historical volatility over the last 90 days
Alvotech has high likelihood to experience some financial distress in the next 2 years
Alvotech currently holds 1.19 B in liabilities. Alvotech has a current ratio of 0.84, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Alvotech's use of debt, we should always consider it together with its cash and equity.
The entity reported the previous year's revenue of 489.68 M. Net Loss for the year was (231.86 M) with profit before overhead, payroll, taxes, and interest of 357.09 M.
Alvotech currently holds about 128.44 M in cash with (236.84 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.52.
Roughly 63.0% of the company shares are held by company insiders
Latest headline from gurufocus.com: Alvotech and Advanz Pharma Announce Strategic Partnership for Biosimilar AVT10 ALVO stock news

Alvotech Upcoming and Recent Events

Earnings reports are used by Alvotech to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period..
6th of March 2024
Upcoming Quarterly Report
View
17th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
6th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Alvotech Largest EPS Surprises

Earnings surprises can significantly impact Alvotech's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2024-11-20
2024-09-30-0.063-0.030.03352 
2022-11-15
2022-09-300.02-0.0346-0.0546273 
2025-03-26
2024-12-310.01-0.1421-0.15211521 
View All Earnings Estimates

Alvotech Thematic Classifications

In addition to having Alvotech stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
IT Idea
IT
Information technology and IT services
Health Management Idea
Health Management
Healthcare providers, hospitals
Drugs Idea
Drugs
Drug manufacturing and delivery

Alvotech Market Capitalization

The company currently falls under 'Mid-Cap' category with a current market capitalization of 2.84 B.

Alvotech Profitablity

The company has Profit Margin (PM) of 0.16 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.08 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.08.

Management Efficiency

Alvotech has return on total asset (ROA) of 0.0702 % which means that it generated a profit of $0.0702 on every $100 spent on assets. This is way below average. Alvotech's management efficiency ratios could be used to measure how well Alvotech manages its routine affairs as well as how well it operates its assets and liabilities. As of the 7th of July 2025, Non Currrent Assets Other is likely to grow to about 27.7 M, while Total Assets are likely to drop about 895.9 M.
The leadership approach at Alvotech's fosters a culture of excellence and accountability. Our analysis examines how this culture influences financial outcomes and stock valuation.
Operating Margin
0.0797
Profit Margin
0.1642
Beta
0.191
Return On Assets
0.0702

Technical Drivers

As of the 7th of July, Alvotech shows the Downside Deviation of 3.08, mean deviation of 2.77, and Risk Adjusted Performance of 0.006. Alvotech technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.

Alvotech Price Movement Analysis

Execute Study
The output start index for this execution was twenty-three with a total number of output elements of thirty-eight. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Alvotech middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Alvotech. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.

Alvotech Predictive Daily Indicators

Alvotech intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Alvotech stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Alvotech Forecast Models

Alvotech's time-series forecasting models are one of many Alvotech's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Alvotech's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About Alvotech Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Alvotech prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Alvotech shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Alvotech. By using and applying Alvotech Stock analysis, traders can create a robust methodology for identifying Alvotech entry and exit points for their positions.
Alvotech, through its subsidiaries, develops and manufactures biosimilar medicines for patients worldwide. The company was founded in 2013 and is headquartered in Reykjavik, Iceland. Alvotech is traded on NASDAQ Exchange in the United States.

Current Alvotech Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Alvotech analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Alvotech analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
18.0Buy4Odds
Alvotech current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Alvotech analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Alvotech stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Alvotech, talking to its executives and customers, or listening to Alvotech conference calls.
Alvotech Analyst Advice Details

Alvotech Stock Analysis Indicators

Alvotech stock analysis indicators help investors evaluate how Alvotech stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Alvotech shares will generate the highest return on investment. By understating and applying Alvotech stock analysis, traders can identify Alvotech position entry and exit signals to maximize returns.
Begin Period Cash Flow11.2 M
Long Term DebtB
Common Stock Shares Outstanding267.9 M
Total Stockholder Equity-412.8 M
Tax Provision14.3 M
Quarterly Earnings Growth Y O Y-0.696
Property Plant And Equipment Net409.7 M
Cash And Short Term Investments51.4 M
Cash51.4 M
Accounts Payable67.1 M
Net Debt1.1 B
50 Day M A9.6021
Total Current Liabilities193.4 M
Other Operating Expenses420 M
Non Current Assets Total766.4 M
Forward Price Earnings45.6621
Non Currrent Assets Other26.3 M
Stock Based Compensation7.6 M
When determining whether Alvotech offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Alvotech's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Alvotech Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Alvotech Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Alvotech. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.
To learn how to invest in Alvotech Stock, please use our How to Invest in Alvotech guide.
You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Alvotech. If investors know Alvotech will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Alvotech listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.70)
Earnings Share
0.37
Revenue Per Share
2.124
Quarterly Revenue Growth
2.6
Return On Assets
0.0702
The market value of Alvotech is measured differently than its book value, which is the value of Alvotech that is recorded on the company's balance sheet. Investors also form their own opinion of Alvotech's value that differs from its market value or its book value, called intrinsic value, which is Alvotech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Alvotech's market value can be influenced by many factors that don't directly affect Alvotech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Alvotech's value and its price as these two are different measures arrived at by different means. Investors typically determine if Alvotech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Alvotech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.